Memphis, TN, United States of America

Jeanine Price


Average Co-Inventor Count = 10.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Jeanine Price: Innovator in Pharmaceutical Research

Introduction

Jeanine Price is a notable inventor based in Memphis, TN (US). She has made significant contributions to the field of pharmaceutical research, particularly in the development of compounds that modulate protein activity. With a total of 2 patents to her name, her work is paving the way for advancements in treating various clinical conditions.

Latest Patents

Jeanine's latest patents include the development of substituted N-(2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-5-yl)arylsulfonamide analogs. These compounds are recognized for their potential as modulators of cereblon protein activity. The patents detail methods of making these compounds, pharmaceutical compositions that include them, and their application in treating disorders associated with uncontrolled cellular proliferation, such as cancer. The disclosed compounds can selectively modulate the degradation of GSPT1 protein, acting as GSPT1 degraders, which is crucial for addressing protein dysfunctions in various diseases.

Career Highlights

Jeanine Price is currently affiliated with St. Jude Children's Research Hospital, where she continues her innovative work in pharmaceutical research. Her contributions are vital in the ongoing efforts to develop effective treatments for complex medical conditions.

Collaborations

Some of her notable coworkers include Fatemeh Keramatnia and Kevin McGowan, who collaborate with her on various research projects.

Conclusion

Jeanine Price's work exemplifies the impact of innovation in the pharmaceutical industry. Her patents and research efforts are instrumental in advancing medical science and improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…